Predict your next investment

Corporation
capitolhealth.com.au

See what CB Insights has to offer

About Capitol Health

Capitol Health is a leading provider of diagnostic imaging services to the Australian healthcare market. Headquartered in Melbourne, Victoria the Company owns and operates clinics throughout Metropolitan Melbourne, Regional Victoria and Tasmania.

Capitol Health Headquarter Location

81 Lorimer Street Level 3

Docklands, Victoria, 3008,

Australia

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Capitol Health News

Capitol Health : ASX Announcement

Feb 26, 2021

Message : All correspondence to: PO Box 836 Port Melbourne VIC 3207 ASX ANNOUNCEMENT Results for the Half-Year Ended 31 December 2020 Capitol Health Limited (Capitol or the Company) (ASX: CAJ) announces its results for the half-year ended 31 December 2020 (1H FY21) and releases its Appendix 4D. Company highlights and commentary 1H FY21: • Revenue of $85.3m, an increase of $4.7m or 5.9% on previous corresponding period (pcp) • Statutory EBITDA of $22.6m, an increase of $6.6m or 41.4% on pcp • Operating EBITDA of $26.6m, an increase of $8.9m or 50.1% on pcp • Operating Margin of 31.1% up from 22.0% for pcp • Statutory NPAT of $6.2m, an increase of $3.5m or 131.6% on pcp • Interim dividend payment maintained at 0.5 cps fully franked Capitol Health has delivered revenue for the half-year to 31 December 2020 of $85.3m, up 5.9% from $80.6m in the previous corresponding period (pcp). The operating EBITDA is $26.6m (up $8.9m or 50.1% compared to pcp) which represents an operating margin of 31.1%. The fully franked interim dividend of 0.5 cents per share has been maintained. Capitol Health's Managing Director and Chief Executive Officer Justin Walter said "The Company continues to organically grow primarily driven by the initiatives identified in our strategic plan. The strong half year result vindicates our view that we remain well on track to deliver this plan despite the challenges of managing through the Covid-19 pandemic and the fluctuating demand for services." Covid-19 pandemic impact The revenue of the Company was impacted by the second lockdown period that occurred in Victoria as a result of the Covid-19 pandemic. Despite this the revenue of the Company ultimately increased for the half-year in comparison to the previous corresponding period due to organic growth initiatives, indexation of certain Medicare rebates, and the benefit of newly acquired businesses. The Company was a recipient of the JobKeeper scheme and received $5.8m net of payment of wage top-ups in line with government policy during the half-year. The JobKeeper payments enabled the Company to retain highly trained medical professionals and support staff during the lockdown period in Victoria and through reduced demand for services. With the second lockdown for Covid-19 in Victoria and general trading conditions management continued to maintain tight control over the cost base of the business with particular focus on matching staff levels to patient demand, and where appropriate temporary closure of sites. The Company also received the government supported business cashflow relief on income tax but this was eventually fully repaid in early December 2020. Outlook for FY21 Following the acquisition of Direct Radiology on 1 February 2021, the Company will focus on full integration of this asset by end of year. In addition, the Company plans to continue organic growth via greenfield and brownfield developments. Strategic priorities for the current year include: • Ongoing investment in systems, people, and capability to enhance our referrer relationships • Continue to measure and enhance the patient experience • Review of information and communication technology in support of clinics, referrers and patients The medical imaging industry growth continues to be supported by population growth, an aging population and MBS re-indexation. The Company believes it is well placed to grow with our community clinics' locations and robust defensive bulk-billing revenue remaining the dominant component of revenue for the business. Mr. Justin Walter, Managing Director, commented "Despite the second lockdown in Victoria during this reporting period, our valued clinicians and support staff continue to provide enhanced care and service to our patients and referrers. We are well placed as one team to continue the growth and transformation of Capitol Health, delivering value for all." For further information, please contact: Craig Bremner Chief Financial Officer (03)9348 3333 investors@capitolhealth.com.au This announcement is authorised for release to the market by the Board of Directors of Capitol Health Limited. About Capitol Health Capitol Health is a leading provider of diagnostic imaging and related services to the Australian healthcare market. Headquartered in Melbourne, Victoria, the Company owns and operates clinics throughout Victoria, Tasmania, South Australia and Western Australia. The Company's operational focus is on delivering a community-based infrastructure for radiologists and related medical practitioners to deliver optimal, efficient, accurate healthcare service outcomes for patients. Capitol also has an investment in diagnostic imaging artificial intelligence through Enlitic Inc in the US. Attachments

Capitol Health Acquisitions

2 Acquisitions

Capitol Health acquired 2 companies. Their latest acquisition was Uniradiology - Frankston, Dandenong, Boronia, Carlton Clinics on January 17, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/17/2019

$991

Acquired Unit

1

1/14/2019

Subscribe to see more

$991

$99M

Subscribe to see more

10

Date

1/17/2019

1/14/2019

Investment Stage

Companies

Subscribe to see more

Valuation

$991

$991

Total Funding

$99M

Note

Acquired Unit

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.